Abstract
This study showed that the Abbott RealTime High RiskHPVassay fulfilled cross-sectional clinical equivalence and reproducibility criteria of international consensus guidelines, which indicates that this assay can be considered clinically validated for cervical cancer screening purposes. © 2013, American Society for Microbiology.
Cite
CITATION STYLE
Hesselink, A. T., Meijer, C. J. L. M., Poljak, M., Berkhof, J., Van Kemenade, F. J., Van Der Salm, M. L., … Heideman, D. A. M. (2013). Clinical validation of the Abbott RealTime high risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening. Journal of Clinical Microbiology, 51(7), 2409–2410. https://doi.org/10.1128/JCM.00633-13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
